FRI0333 ASSESSING SYSTEMIC SCLEROSIS CARDIAC INVOLVEMENT USING MAGNETIC RESONANCE T1-MOLLI MAPPING. (June 2019)

• Record Type: Journal Article
• Authors: Ng, Sue-Ann; Marchesseau, Stephanie; Allen, John Carson; Totman, John; Low, Andrea
• Is Part Of: Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
• Page Start: 848
• Page End: 848
• Publication Date: 2019-06
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-eular.6892
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Patients with systemic sclerosis (SSc) and symptomatic cardiac involvement have a disease-associated mortality of 20% in 10 years. Prevalence of subclinical cardiac involvement is 15%-35%. Early diagnosis and monitoring is therefore critical in the management of SSc-associated cardiac involvement. Conventional cardiac magnetic resonance imaging (cMRI) T1-weighted sequence with late gadolinium contrast has good accuracy for detecting localized fibrosis but not diffuse fibrosis that occurs in SSc. Modified look-locker inversion recovery (T1-MOLLI) mapping, a novel cMRI sequence, has been used to detect and quantify diffuse fibrosis in aortic stenosis. T1-MOLLI values have also been correlated with the degree of biopsy-quantified fibrosis. Objectives: To investigate whether cMRI T1-MOLLI is able to detect fibrosis associated with SSc cardiac involvement. Methods: We recruited 16 patients fulfilling the 2013 ACR/EULAR criteria for SSc and 17 healthy age-matched (within 5 years) controls. Patients underwent cMRI T1-MOLLI mapping on the Siemens Biograph mMR 3.0T (Erlanger, Germany). T1-MOLLI values were compared between SSc patients and healthy controls using student t-test and statistical significance was taken to be p<0.05. Results: Demographics and clinical features of our study cohort are as shown in Table 1 . Two (12.5%) SSc patients were symptomatic with palpitations or had arrhythmia requiring treatment. Eleven (68.8%) SSc patients had elevated T1 MOLLI values, using a normal cut-off threshold of 1284 ms. Mean cardiac T1 values were significantly higher in SSc patients (1329 ± 88.0 ms) than in controls (mean T1 = 1238 ± 93.7 ms, p=0.0075), indicating the presence of cardiac fibrosis. Conclusion: cMRI T1-MOLLI mapping demonstrated that SSc patients who were predominantly asymptomatic showed evidence of cardiac fibrosis. cMRI T1-MOLLI is potentially a useful diagnostic and monitoring tool for SSc cardiac disease. Disclosure of Interests: None declared